Safety and Efficacy of Liposomal Amphotericin B for Patients With Invasive Mold Diseases in Liver Transplant Recipients

NCT07725874 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Invasive Mold Diseases

Interventions

DRUG: AmBisome (Amphotericin B) Liposome

Sponsor

Beijing Friendship Hospital